PedAM
Pediatric Disease Annotations & Medicines
| Disease | rheumatoid arthritis |
| Symptom | |cardiovascular disease |
| Sentences | 60 |
| PubMedID- 22360682 | Lack of association between tlr4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25011482 | Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23244227 | cardiovascular diseases in patients with rheumatoid arthritis. |
| PubMedID- 20868308 | Objectives: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd). |
| PubMedID- 22337612 | Apolipoprotein b-containing lipoprotein subclasses as risk factors for cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24498229 | In observational studies the finding of incident cardiovascular disease in patients with rheumatoid arthritis exposed to glucocorticoids is strongly confounded by indication due to high disease activity. |
| PubMedID- 24585741 | Objective: despite numerous studies reporting increased cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra), the impact of ra on managing modifiable cvd risk factors remains understudied. |
| PubMedID- 23749610 | Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study. |
| PubMedID- 23983474 | The effects of the il-6r and il-6st/gp130 genes on the risk for cardiovascular disease in patients with rheumatoid arthritis were assessed in patients with rheumatoid arthritis who were genotyped for the functional gene polymorphisms. |
| PubMedID- 23666917 | Objective: rheumatoid arthritis (ra) is associated with cardiovascular disease (cvd), but little is known about its association with another form of vascular disorder, venous thromboembolism (vte). |
| PubMedID- 21385539 | Lack of association between lep rs2167270 (19 g>a) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25026799 | cardiovascular diseases in patients with rheumatoid arthritis during long-term methotrexate therapy. |
| PubMedID- 24458537 | The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 22337246 | Hypothyroidism as a risk factor for development of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21109513 | cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives. |
| PubMedID- 21180241 | Platelet histogram indices and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21269581 | Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23204310 | Atherosclerosis and cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 20638217 | Objective: this paper describes the rationale and design of a theory-informed patient education programme addressing cardiovascular disease for people with rheumatoid arthritis (ra) to illustrate how theory can explicitly be translated into practice. |
| PubMedID- 24511540 | Suggests that vegfa polymorphisms do not seem to exert a significant influence on the risk of cardiovascular disease in patients with rheumatoid arthritis 6. |
| PubMedID- 20735865 | Palomino-morales and colleagues 1 report the novel observation that a common polymorphism in the gene for methylene tetrahydrofolate reductase (mthfr) that markedly reduces enzyme activity (by as much as 65% in homozygotes) may predispose to the development of atherosclerotic cardiovascular disease (ascvd) in patients with rheumatoid arthritis (ra). |
| PubMedID- 20164773 | cardiovascular disease in rheumatoid arthritis: a step forward. |
| PubMedID- 26117596 | Prevention of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 24795506 | Lack of association between abo, ppap2b, adamst7, pik3cg, and ednra and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 25754335 | rheumatoid arthritis (ra) associates with increased cardiovascular disease (cvd) mortality thought to be due to accelerated arterial disease. |
| PubMedID- 22249350 | Risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22927710 | Genetic markers of cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 21420089 | Tnfa -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 20827876 | cardiovascular disease in rheumatoid arthritis: disease and treatment interactions and their implications on treatment decisions. |
| PubMedID- 20383550 | Atherosclerosis plays a key role in cardiovascular disease in patients with rheumatoid arthritis (ra). |
| PubMedID- 24874661 | Bacteria in the adventitia of cardiovascular disease patients with and without rheumatoid arthritis. |
| PubMedID- 23256829 | Traditional cardiovascular risk factors only partly explain increased risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21411091 | Prediction of genetic risk for cardiovascular disease in patients with rheumatoid arthritis: present and promises. |
| PubMedID- 22284683 | We also suggest strategies for risk stratification and treatment of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 21388351 | Vascular endothelial growth factor a and cardiovascular disease in rheumatoid arthritis patients. |
| PubMedID- 21276397 | Excess mortality from cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23584985 | Novel risk factors for cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 22521305 | Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 23818136 | Objective: to determine whether the impact of aging on cardiovascular disease (cvd) risk in patients with rheumatoid arthritis (ra) differs from that in the general population (as estimated by the framingham risk score frs). |
| PubMedID- 22935383 | Objectives: the impact of metabolic risk factors on atherosclerotic cardiovascular disease (acvd) in patients with rheumatoid arthritis (ra) from developing populations is currently unknown. |
| PubMedID- 22513132 | The excess risk of cardiovascular disease (cvd) associated with rheumatoid arthritis (ra) has long been recognized . |
| PubMedID- 21520672 | Excess mortality from cardiovascular disease in patients with rheumatoid arthritis--nsaid a possible cause. |
| PubMedID- 21073447 | To assess the potential association between adipoq rs266729 and rs1501299 gene polymorphisms, either isolated or in combination, and cardiovascular disease in patients with rheumatoid arthritis (ra), 674 patients seen at the rheumatology outpatient clinics of hospital xeral-calde, lugo, and hospital san carlos, madrid, spain, were analyzed. |
| PubMedID- 21846359 | Ccr5delta32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study. |
| PubMedID- 20952464 | Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. |
| PubMedID- 23300117 | Objectives: to assess the effect of golimumab, with or without methotrexate (mtx), on serum lipids and inflammatory markers of cardiovascular disease (cvd) in patients with rheumatoid arthritis (ra) in two phase 3, randomised, placebo-controlled trials (go-before and go-forward). |
| PubMedID- 23193471 | cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america. |
| PubMedID- 24498997 | Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis. |
| PubMedID- 24268008 | cardiovascular disease in rheumatoid arthritis. |
| PubMedID- 26082375 | Pathophysiologic mechanisms and risk management of cardiovascular disease in patients with rheumatoid arthritis. |
Page: 1 2